Video Experimental Relacionado
Updated: Aug 4, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Productos farmacéuticos: su papel en el desarrollo de las sociedades en desarrollo
Science (New York, N.Y.)
|July 11, 1980
Resumen
El desarrollo de nuevos sistemas de desarrollo de fármacos, no sólo medicamentos, es crucial para hacer frente a las principales enfermedades en los países en desarrollo. Este enfoque adapta la I + D a necesidades financieras y biológicas específicas, mejorando la equidad en salud global.
Área de la Ciencia:
- Salud global La salud global.
- Investigación y Desarrollo Farmacéutico.
- Evaluación de la tecnología de la salud Evaluación de la tecnología de la salud
Sus antecedentes:
- Las estrategias de control de enfermedades difieren significativamente entre las naciones desarrolladas y en desarrollo.
- Los éxitos actuales de la industria farmacéutica se centran principalmente en tratamientos administrados individualmente, que son menos aplicables a los desafíos de salud pública de los países en desarrollo.
- Los modelos de I + D existentes no abordan adecuadamente los contextos económicos y biológicos únicos de las enfermedades en las regiones en desarrollo.
Objetivo del estudio:
- Defender un cambio de paradigma en la I+D farmacéutica para servir mejor a los países en desarrollo.
- Para resaltar la necesidad de nuevos sistemas, en lugar de nuevos medicamentos, para hacer frente a las enfermedades prevalentes en las naciones de bajos ingresos.
- Proponer un marco de I+D adaptado a las realidades financieras y biológicas específicas de las economías en desarrollo.
Principales métodos:
- Análisis conceptual y argumentación.
- Revisión de las tecnologías de control de enfermedades existentes y los modelos de I + D farmacéuticos.
- Evaluación comparativa de las necesidades de salud en los países industrializados frente a los países en desarrollo.
Principales resultados:
- El modelo dominante de I+D en la industria farmacéutica está desalineado con las preocupaciones primarias de salud de los países en desarrollo.
- La necesidad no satisfecha más significativa no es para nuevas terapias, sino para sistemas innovadores de I + D.
- Un sistema de I + D a medida es esencial para desarrollar medicamentos que sean financieramente viables y biológicamente efectivos para el control generalizado de enfermedades en los países en desarrollo.
Conclusiones:
- La industria farmacéutica debe innovar sus sistemas de I + D para abordar eficazmente las disparidades mundiales de salud.
- El futuro desarrollo de drogas para los países en desarrollo requiere un enfoque en soluciones accesibles, orientadas al grupo y económicamente viables.
- Repensar el proceso de I+D es fundamental para mejorar el impacto de las intervenciones farmacéuticas en regiones económicamente subdesarrolladas.
Videos de Conceptos Relacionados
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...